Related Experiment Video
Updated: May 24, 2025

08:40
Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting
Published on: March 1, 2019
58.9K
Host cell entry and neutralisation sensitivity of the emerging SARS-CoV-2 variant LP.8.1
Lu Zhang1, Amy Kempf2, Inga Nehlmeier1
1Infection Biology Unit, German Primate Center, 37077 Göttingen, Germany.
The Lancet. Infectious Diseases
|March 1, 2025
Abstract
No abstract available in PubMed .

